Projects per year
Fingerprint
Dive into the research topics where Susan Swindells is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center
Buch, S. J. (CoPI), Buch, S. J. (PI), Boska, M. D. (CoPI), Ciborowski, P. S. (CoPI), Fox, H. S. (CoPI), Gendelman, H. E. (CoPI), Gorantla, S. (CoPI), Sajja, B. R. (CoPI), Swindells, S. (CoPI), Sarvetnick, N. E. (CoPI), Wilson, T. W. (CoPI), Fox, H. S. (CoPI) & Wood, C. (CoPI)
Project: Research project
-
-
SCRIPPS NEUROAIDS PRECLINICAL STUDIES (SNAPS)
Ciborowski, P. S. (PI), Boska, M. D. (PI), Gendelman, H. E. (PI), Wood, C. (PI), Swindells, S. (PI), Sarvetnick, N. E. (PI), Fox, H. S. (PI), Ideker, T. (PI), Buch, S. (PI), Taffe, M. (PI), Elder, J. (PI), Dawson, P. (PI), Henriksen, S. (PI), Campbell, I. L. (PI), Buch, S. J. (PI), Gorantla, S. (PI), Fox, H. S. (CoPI) & Wilson, T. W. (PI)
9/30/00 → 2/28/17
Project: Research project
-
Bookends
Swindells, S., Mar 17 2025, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 80, 3, p. 494-496 3 p.Research output: Contribution to journal › Article › peer-review
-
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
AIDS Clinical Trials Group A5349 & Tuberculosis Trials Consortium Study 31, Mar 2025, In: Emerging infectious diseases. 31, 3, p. 467-476 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis
Covington, N., Luetkemeyer, A. F., Imperial, M. Z., Dawson, R., Cramer, Y., Rosenkranz, S., Swindells, S., Gelmanova, I., Avihingsanon, A., Arduino, R. C., Samaneka, W., Dooley, K. E., Savic, R., Podany, A. T. & Haas, D. W., 2025, (Accepted/In press) In: Pharmacogenetics and Genomics. 0562.Research output: Contribution to journal › Article › peer-review
Open Access -
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries
Furl, R., Scarsi, K. K., Sayles, H., Anderson, M., Ofimboudem, J. D., Weld, E. D., Waked, I., Gomaa, A., Al-Khatib, A., Elshobary, F. M., Desalegn, H., Fisseha, H., Solomon, S., Mehta, S., Owen, A., Rannard, S., Thomas, D. L. & Swindells, S., Apr 2025, In: Journal of Viral Hepatitis. 32, 4, e14031.Research output: Contribution to journal › Article › peer-review
-
Week 96 Results of Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in People with Substance Use Disorders
Havens, J. P., Bares, S. H., Lyden, E., Fadul, N. & Swindells, S., Jan 1 2025, In: Open Forum Infectious Diseases. 12, 1, ofae737.Research output: Contribution to journal › Article › peer-review
Open Access